Stay Updated

News & Reports

For all press requests, please reach out to [email protected].

News and Reports

India Post News: How Soaring Costs Are Reshaping Health Care Access?

Merith Basey, Executive Director, Patients for Affordable Drugs stated that the persistently high drug prices in the United States are primarily due to pharmaceutical companies maintaining market monopolies through the patent system. Drug prices are entirely set by the pharmaceutical companies themselves, with a lack of government negotiation mechanisms. She pointed out that research shows […]

News and Reports

WRTV Indianapolis: Scammers take advantage of popularity of GLP-1 drugs

As the Better Business Bureau tracks complaints about GLP-1-related scams, Patients for Affordable Drugs is tracking GLP-1 prices. The national patient advocacy organization says the injectables are still too costly for many Americans. “The issue is largely driven by the power of the pharmaceutical industry and the monopoly power they have over setting prices,” said […]

News and Reports

Axios: Drug prices to keep rising through Trump's term

Advocacy group Patients for Affordable Drugs said in response to the survey results that the IRA’s reforms are working for seniors. “[T]hat’s exactly why expanding and protecting the law matters,” Alyson Bancroft, director of policy, legislation and alliances, told Axios in an email. Health and Human Services communications director Andrew Nixon told Axios the agency […]

News and Reports

Epoch Times: Lower Prices for 10 Medicare Drugs Now in Effect: What to Know

Merith Basey, CEO for Patients For Affordable Drugs, said the negotiation brought overdue accountability to pharmaceutical manufacturers who have long charged higher prices to U.S. customers than to those in other countries. “This is a historic step, but it cannot be the last,” Basey said in a Jan. 1 statement. “Medicare negotiation must be protected, […]

News and Reports

Bloomberg: Cancer’s Soaring Cost Wrecks Patients’ Finances in a Broken System

As part of the Inflation Reduction Act in 2022, Congress capped patient out-of-pocket costs at $2,000 in the Medicare prescription drug program. Trapp, who’s now a patient advocate for a non-profit group called Patients for Affordable Drugs, said that helped limit her own expenses once she qualified for Medicare through disability. But the cap only applies […]